Patents by Inventor Nicolas Jean Benoit MONIOTTE

Nicolas Jean Benoit MONIOTTE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VACCINE
    Publication number: 20240131136
    Abstract: The present invention is in the field of pneumococcal capsular saccharide conjugate vaccines. Specifically, the present invention relates to sized Streptococcus pneumoniae serotype 6A capsular polysaccharides, in particular Streptococcus pneumoniae serotype 6A capsular polysaccharides having the average size (e.g. Mw) of the Streptococcus pneumoniae serotype 6A capsular polysaccharide is between 100-1000 kDa, suitably conjugated to a carrier protein.
    Type: Application
    Filed: November 1, 2023
    Publication date: April 25, 2024
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Elisabeth Marie Monique BERTAUD, Ralph Leon BIEMANS, Nicolas Jean Benoit MONIOTTE, Laurent Bernard Jean STRODIOT
  • Vaccine
    Patent number: 11844828
    Abstract: The present invention is in the field of pneumococcal capsular saccharide conjugate vaccines. Specifically, the present invention relates to sized Streptococcus pneumoniae serotype 6A capsular polysaccharides, in particular Streptococcus pneumoniae serotype 6A capsular polysaccharides having the average size (e.g. Mw) of the Streptococcus pneumoniae serotype 6A capsular polysaccharide is between 100-1000 kDa, suitably conjugated to a carrier protein.
    Type: Grant
    Filed: October 19, 2016
    Date of Patent: December 19, 2023
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Elisabeth Marie Monique Bertaud, Ralph Leon Biemans, Nicolas Jean Benoit Moniotte, Laurent Bernard Jean Strodiot
  • Vaccine
    Publication number: 20180303923
    Abstract: The present invention is in the field of pneumococcal capsular saccharide conjugate vaccines. Specifically, the present invention relates to sized Streptococcus pneumoniae serotype 6A capsular polysaccharides, in particular Streptococcus pneumoniae serotype 6A capsular polysaccharides having the average size (e.g. Mw) of the Streptococcus pneumoniae serotype 6A capsular polysaccharide is between 100-1000 kDa, suitably conjugated to a carrier protein.
    Type: Application
    Filed: October 19, 2016
    Publication date: October 25, 2018
    Applicant: GLAXOSMITHKLINE BIOLOGICALS, SA
    Inventors: Elisabeth Marie Monique BERTAUD, Ralph Leon BIEMANS, Nicolas Jean Benoit MONIOTTE, Laurent Bernard Jean STRODIOT